• HELEN ALBERT
• 23 Oct, 2019

Artificial intelligence has been much discussed of late, but will it really help us solve important problems like how to bring personalized medicine to as many patients as possible? Kate Hilyard, COO of Healx in Cambridge in the UK, believes it can. Getting a drug to clinical trials currently requires a large investment of both time and money with no guarantee that it will be successful in the long term, or reach the market.
Read more...